Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038379 (
strabismus
)
9,317
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
According to Bjerrum [5] and Ammann [2], light attenuation decreases visual acuity at different rates in normals, organic and functional amblyopes. In 27 normal subjects, 19 patients with central fixating
squint
amblyopia and 12 with organically poor vision, we determined the visually evoked cortical potential (VECP) threshold check size, P100 latency and P2 amplitude for reversing checkerboards of variable size at different levels of luminance. After light attenuation, we found a different rate of change for VECP threshold check size in normal subjects and patients with
squint
amblyopia, which lessened after the fovea was occluded. With suprathreshold checks, normal subjects and patients with
squint
amblyopia exhibited significantly smaller amplitude/latency changes after light attenuation than patients with organically poor vision. Only patients with
squint
amblyopia exhibiting a visual acuity of greater than 0.2 showed smaller VECP changes than normal subjects during light attenuation. According to these findings, the different rate of change in visual acuity after light attenuation in normal subjects and patients with
squint
amblyopia is locus specific [7] rather than luminance specific [12, 13]. We conclude that cortical
disinhibition
of the parafoveal retina [20] is responsible for the preservation of visual acuity in
squint
amblyopia during light attenuation.
...
PMID:[VECP (pattern threshold, amplitude, latency) in different light levels. A comparison between healthy eyes, organic and functional amblyopia eyes]. 185 45